CIK 0001706431 · Large accelerated filer
Vir Biotechnology, Inc.
Sign in to watch- Ticker
- VIR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 812730369
- Phone
- 415-906-4324
- Business address
- 1800 OWENS STREET, SUITE 900, SAN FRANCISCO, CA, 94158
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $41,939
- in 1 filing, $42K under 10b5-1 plans
Net −$41,939. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 46 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-09-16 | Pang Phillip Chief Medical Officer | Sale | −5,000 | $31.92 | $160K | 29,777 |
| 2020-09-16 | Pang Phillip Chief Medical Officer | Option exercise · Employee Stock Option (Right to Buy) | −9,720 | 53,242 | ||
| 2020-09-16 | Pang Phillip Chief Medical Officer | Option exercise · Employee Stock Option (Right to Buy) | −465 | 110,646 | ||
| 2020-09-16 | Pang Phillip Chief Medical Officer | Option exercise · Employee Stock Option (Right to Buy) | −2,315 | 69,444 | ||
| 2020-09-08 | Virgin Herbert EVP, Research & CSO | Option exercise | +3,805 | $1.53 | $6K | 23,805 |
| 2020-09-08 | Virgin Herbert EVP, Research & CSO | Sale | −1,465 | $30.00 | $44K | 22,340 |
| 2020-09-08 | Virgin Herbert EVP, Research & CSO | Sale | −2,340 | $29.98 | $70K | 20,000 |
| 2020-09-08 | Virgin Herbert EVP, Research & CSO | Option exercise · Stock Option (Right to Buy) | −3,805 | 470,890 | ||
| 2020-09-02 | Pang Phillip Chief Medical Officer | Option exercise | +12,500 | $1.58 | $20K | 42,277 |
| 2020-09-02 | Pang Phillip Chief Medical Officer | Sale | −7,500 | $32.88 | $247K | 34,777 |
| 2020-09-02 | Pang Phillip Chief Medical Officer | Sale | −5,000 | $32.91 | $165K | 29,777 |
| 2020-09-02 | Pang Phillip Chief Medical Officer | Option exercise · Employee Stock Option (Right to Buy) | −12,500 | 62,962 | ||
| 2020-09-01 | Parrish Jay Chief Business Officer | Option exercise | +6,943 | $1.58 | $11K | 229,165 |
| 2020-09-01 | Parrish Jay Chief Business Officer | Sale | −6,943 | $39.15 | $272K | 222,222 |
| 2020-09-01 | Parrish Jay Chief Business Officer | Option exercise · Stock Option (Right to Buy) | −6,943 | 53,241 | ||
| 2020-08-28 | Napolitano Janet Director | Grant or award · Stock Option (Right to Buy) | +33,000 | 33,000 | ||
| 2020-08-25 | Virgin Herbert EVP, Research & CSO | Option exercise | +25,560 | $1.53 | $39K | 25,560 |
| 2020-08-25 | Virgin Herbert EVP, Research & CSO | Sale | −5,560 | $42.92 | $239K | 20,000 |
| 2020-08-25 | Virgin Herbert EVP, Research & CSO | Option exercise · Stock Option (Right to Buy) | −25,560 | 474,695 | ||
| 2020-08-19 | Pang Phillip Chief Medical Officer | Option exercise | +10,185 | $1.58 | $16K | 25,962 |
Page 51 of 54 · 1,063 trades